Moderna’s Coronavirus Vaccine Trial is Fully Enrolled with 37% Minorities


Moderna Could Seek Approval in November

Health Editor’s Note: The main issues other than safety and efficacy is that the vaccine/trials will be representative of the U.S. population. Recruitment has slowed the process but now there are 30,000 participants with 25% over 65, one fifth Hispanic, and 10% Black. 

Pfizer, which is not a part of the Operation Warp Speed, a federal program to speed up COVID-19 vaccine research and production, also has a large trial in the works with 39,862 participants. Both the Moderna and Pfizer trials have given the second booster dose of vaccine…..Carol   

Due to the nature of independent content, VT cannot guarantee content validity.
We ask you to Read Our Content Policy so a clear comprehension of VT's independent non-censored media is understood and given its proper place in the world of news, opinion and media.

All content is owned by author exclusively. Expressed opinions are NOT necessarily the views of VT, other authors, affiliates, advertisers, sponsors, partners or technicians. Some content may be satirical in nature. All images within are full responsibility of author and NOT VT.

About VT - Read Full Policy Notice - Comment Policy